Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression and Alzheimer's disease

L E Tune1

  • 1Wesley Woods Center on Aging, Emory University School of Medicine, Atlanta, Georgia 30329, USA.

Depression and Anxiety
|November 11, 1998
PubMed
Summary

Depressive symptoms are common in Alzheimer's disease and can cause excess disability. Antidepressant therapy, particularly SSRIs, is effective for treating depression in dementia patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticholinergic effects of medication in elderly patients.

The Journal of clinical psychiatry·2001
Same author

Risperidone for the treatment of behavioral and psychological symptoms of dementia.

The Journal of clinical psychiatry·2001
Same author

Serum anticholinergic activity levels and delirium in the elderly.

Seminars in clinical neuropsychiatry·2000
Same author

Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder.

The American journal of psychiatry·2000
Same author

Acetylcholine and delirium.

Dementia and geriatric cognitive disorders·1999
Same author

New cholinergic therapies: treatment tools for the psychiatrist.

The Journal of clinical psychiatry·1998

Area of Science:

  • Geriatric Psychiatry
  • Neuroscience
  • Clinical Psychology

Background:

  • Depressive symptoms frequently occur in Alzheimer's disease (AD), encompassing major depression and subsyndromal depression.
  • These symptoms contribute significantly to excess disability in AD patients.
  • The investigation of depression in AD warrants further research due to clinical and methodological complexities.

Purpose of the Study:

  • To highlight the importance of recognizing and treating depressive symptoms in individuals with dementia.
  • To advocate for the consideration of antidepressant therapy in demented patients with clinically significant depression, even if full diagnostic criteria are not met.
  • To outline modified treatment guidelines for depression in dementia.

Main Methods:

  • Review of current understanding and treatment approaches for depression in Alzheimer's disease.
  • Emphasis on early detection and intervention strategies.
  • Consideration of specific antidepressant classes, such as Selective Serotonin Reuptake Inhibitors (SSRIs).

Main Results:

  • Depressive symptoms in dementia patients often respond well to antidepressant therapy.
  • Selective Serotonin Reuptake Inhibitors (SSRIs) with cognitive-enhancing effects are recommended as first-line treatments.
  • Modified treatment approaches are necessary for depression in dementia, including slower titration and attention to cognitive toxicity.

Conclusions:

  • Early detection and treatment of depressive symptoms are crucial in all dementia care settings.
  • Antidepressant therapy can effectively manage depression and reduce excess disability in Alzheimer's disease.
  • Treatment protocols for depression in dementia require adjustments compared to cognitively intact populations.

Related Experiment Videos